Literature DB >> 20537454

Silent brain infarction and rapid decline of kidney function in patients with CKD: a prospective cohort study.

Mayumi Kobayashi1, Nobuhito Hirawa, Satoshi Morita, Keisuke Yatsu, Yusuke Kobayashi, Yuichiro Yamamoto, Sanae Saka, Yoshiyuki Toya, Gen Yasuda, Satoshi Umemura.   

Abstract

BACKGROUND: Several reports have found that chronic kidney disease (CKD) is an independent risk factor for stroke. However, little is known about whether cerebrovascular disease conversely predicts the outcome of kidney function. In view of the similarities between vascular beds of the kidney and brain, we hypothesized that silent brain infarction (SBI) could reflect the degree of injury in renal small vessels and predict the risk of progression of kidney disease. STUDY
DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 142 patients with CKD (stages 3-5) admitted to our clinic for education about CKD from January 2006 to July 2007 were recruited and followed up for 2 years. PREDICTOR: SBI. OUTCOMES: Composite primary outcomes: doubling of serum creatinine level, development of end-stage renal disease defined as dialysis or transplant, and death from cardiovascular causes. Secondary outcome: rate of decrease in estimated glomerular filtration rate. MEASUREMENTS: Brain magnetic resonance imaging was performed to determine the presence or absence of SBI.
RESULTS: At baseline, 87 patients had SBI. During follow-up, 43 patients (30.3%) developed the following primary outcomes: doubling of serum creatinine level (8 patients), dialysis therapy (32 patients), and death from cardiovascular causes (3 patients). In crude analysis, the presence of SBI predicted time to primary outcomes (P=0.01). A multivariate Cox model confirmed the presence of SBI to be an independent predictor of study outcomes (HR, 2.16; 95% CI, 1.01-4.64; P=0.04). Estimated glomerular filtration rate decreased more in patients with SBI than in those without SBI (-0.11/y vs -0.06/y relative to baseline value; P=0.005). LIMITATIONS: Study size was small.
CONCLUSION: We showed that SBI was an important independent prognostic factor for the progression of kidney disease in patients with CKD. Our findings suggest that patients with SBI should be considered a high-risk population for decreased kidney function. Copyright (c) 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20537454     DOI: 10.1053/j.ajkd.2010.03.018

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  9 in total

1.  Cardiorenal syndromes.

Authors:  Peter A McCullough; Aftab Ahmad
Journal:  World J Cardiol       Date:  2011-01-26

2.  Incidence of stroke before and after dialysis initiation in older patients.

Authors:  Anne M Murray; Stephen Seliger; Kamakshi Lakshminarayan; Charles A Herzog; Craig A Solid
Journal:  J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 10.121

3.  Brain Magnetic Resonance Imaging Findings in Children and Young Adults With CKD.

Authors:  Erum A Hartung; Guray Erus; Abbas F Jawad; Nina Laney; Jimit J Doshi; Stephen R Hooper; Jerilynn Radcliffe; Christos Davatzikos; Susan L Furth
Journal:  Am J Kidney Dis       Date:  2018-02-15       Impact factor: 8.860

Review 4.  Kidney-brain crosstalk in the acute and chronic setting.

Authors:  Renhua Lu; Matthew C Kiernan; Anne Murray; Mitchell H Rosner; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2015-08-18       Impact factor: 28.314

5.  Ischemic diabetic retinopathy as a possible prognostic factor for chronic kidney disease progression.

Authors:  W J Lee; L Sobrin; M H Kang; M Seong; Y J Kim; J-H Yi; J W Miller; H Y Cho
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

6.  Cardiorenal syndromes: pathophysiology to prevention.

Authors:  Peter A McCullough
Journal:  Int J Nephrol       Date:  2010-12-01

7.  Calcium channel blocker enhances beneficial effects of an angiotensin II AT1 receptor blocker against cerebrovascular-renal injury in type 2 diabetic mice.

Authors:  Kazi Rafiq; Shamshad J Sherajee; Hirofumi Hitomi; Daisuke Nakano; Hiroyuki Kobori; Koji Ohmori; Hirohito Mori; Hideki Kobara; Tsutomu Masaki; Masakazu Kohno; Akira Nishiyama
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

8.  Stroke and Risks of Development and Progression of Kidney Diseases and End-Stage Renal Disease: A Nationwide Population-Based Cohort Study.

Authors:  Chia-Lin Wu; Chun-Chieh Tsai; Chew-Teng Kor; Der-Cherng Tarng; Ie-Bin Lian; Tao-Hsiang Yang; Ping-Fang Chiu; Chia-Chu Chang
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

9.  Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients?

Authors:  James Tollitt; Stuart M Allan; Rajkumar Chinnadurai; Aghogho Odudu; Margaret Hoadley; Craig Smith; Philip A Kalra
Journal:  BMC Nephrol       Date:  2022-01-18       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.